These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. One more change of paradigm in breast cancer treatment. Postmastectomy radiotherapy for patients with one to three lymph node metastases? Sautter-Bihl ML, Sauer R. Strahlenther Onkol; 2007 Jul; 183(7):357-9. PubMed ID: 17609867 [No Abstract] [Full Text] [Related]
3. [Sequencing of adjuvant treatment after surgery for invasive breast cancer]. Petit T, Claude L, Carrie C. Cancer Radiother; 2004 Feb; 8(1):54-8. PubMed ID: 15093202 [Abstract] [Full Text] [Related]
4. [Radiation and concomitant chemotherapy after surgery for breast cancer]. Calais G. Cancer Radiother; 2004 Feb; 8(1):39-47. PubMed ID: 15093200 [Abstract] [Full Text] [Related]
5. Paradigm shift in adjuvant treatment of receptor positive premenopausal breast cancer patients? Not yet! Samur M, Bozcuk HS. J Clin Oncol; 2003 Jun 15; 21(12):2444; author reply 2445-7. PubMed ID: 12805349 [No Abstract] [Full Text] [Related]
6. [Current trends in the treatment of primary breast cancer]. Letiagin VP. Vopr Onkol; 1998 Jun 15; 44(5):632-5. PubMed ID: 9884732 [No Abstract] [Full Text] [Related]
7. [Adjuvant therapy in breast cancer]. Semiglazov VF. Vopr Onkol; 2000 Jun 15; 46(1):18-27. PubMed ID: 10789218 [No Abstract] [Full Text] [Related]
8. [Recent advance in adjuvant therapy for breast cancer]. Shimizu C, Watanabe T. Gan To Kagaku Ryoho; 2002 Dec 15; 29(13):2458-69. PubMed ID: 12506467 [Abstract] [Full Text] [Related]
9. [Breast carcinoma in accessory gland: a case report]. Sivelli R, Del Rio P, Arcuri MF, Corcione L. G Chir; 2002 May 15; 23(5):179-80. PubMed ID: 12228967 [Abstract] [Full Text] [Related]
10. [Prospective randomized trial on the efficacy of adjuvant endocrine therapy for ER-positive breast cancer patients after radical mastectomy]. Jiang Z, Song S, Liu X. Zhonghua Zhong Liu Za Zhi; 2001 Sep 15; 23(5):420-2. PubMed ID: 11810777 [Abstract] [Full Text] [Related]
11. [Comparison of epirubicin and cyclophosphamide in 2-dose levels and classical CMF protocol in node-positive breast cancer. An adjuvant Phase III trial]. Ost E, Illiger HJ. Strahlenther Onkol; 2002 Jan 15; 178(1):54-5. PubMed ID: 11977396 [No Abstract] [Full Text] [Related]
12. Chemoendocrine therapy for premenopausal women with axillary lymph node-positive, steroid hormone receptor-positive breast cancer: results from INT 0101 (E5188). Davidson NE, O'Neill AM, Vukov AM, Osborne CK, Martino S, White DR, Abeloff MD. J Clin Oncol; 2005 Sep 01; 23(25):5973-82. PubMed ID: 16087950 [Abstract] [Full Text] [Related]
13. Tumor angiogenesis in women with node-positive breast cancer. Folkman J. Cancer J Sci Am; 1995 Sep 01; 1(2):106-8. PubMed ID: 9166461 [No Abstract] [Full Text] [Related]
14. Adjuvant therapy in breast cancer. Robert NJ. Obstet Gynecol Clin North Am; 1994 Dec 01; 21(4):693-707. PubMed ID: 7731642 [Abstract] [Full Text] [Related]
15. Patterns of locoregional failure in patients with operable breast cancer treated by mastectomy and adjuvant chemotherapy with or without tamoxifen and without radiotherapy: results from five National Surgical Adjuvant Breast and Bowel Project randomized clinical trials. Taghian A, Jeong JH, Mamounas E, Anderson S, Bryant J, Deutsch M, Wolmark N. J Clin Oncol; 2004 Nov 01; 22(21):4247-54. PubMed ID: 15452182 [Abstract] [Full Text] [Related]
16. Is the benefit of postmastectomy irradiation limited to patients with four or more positive nodes, as recommended in international consensus reports? A subgroup analysis of the DBCG 82 b&c randomized trials. Overgaard M, Nielsen HM, Overgaard J. Radiother Oncol; 2007 Mar 01; 82(3):247-53. PubMed ID: 17306393 [Abstract] [Full Text] [Related]
17. Treatment of advanced breast cancer: How much chemotherapy is enough? DiPaola RS, Kaufman A, Mikhail MM. Semin Oncol; 1996 Jun 01; 23(3):xv-xxii; discussion xxii-xxiv. PubMed ID: 8658211 [No Abstract] [Full Text] [Related]
18. [Clinical analysis of resectable breast cancer: a report of 6 263 cases]. Yang MT, Rong TH, Huang ZF, Zeng CG, Long H, Fu JH, Lin P, Wang X, Wang SY, Wang X, Tang J. Ai Zheng; 2005 Mar 01; 24(3):327-31. PubMed ID: 15757535 [Abstract] [Full Text] [Related]
19. [Organ preserving treatment of breast cancer]. Topuzov EG, Krasnozhon DA. Vestn Khir Im I I Grek; 2004 Mar 01; 163(3):99-102. PubMed ID: 15317177 [No Abstract] [Full Text] [Related]
20. Ovarian ablation as adjuvant therapy for early-stage breast cancer. Pritchard KI. Cancer Treat Res; 1998 Mar 01; 94():158-80. PubMed ID: 9587687 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]